Could engineered immune cells tame tough lupus kidney disease?
Disease control
Not yet recruiting
This study tests a new treatment called FT819 for people with moderate-to-severe lupus that affects the kidneys (lupus nephritis) and hasn't responded to other therapies. FT819 uses specially engineered immune cells from a donor to target and calm the overactive immune system. Th…
Phase: PHASE2 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC